financetom
Market
financetom
/
Market
/
Sector Update: Health Care
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sector Update: Health Care
Apr 25, 2024 11:03 AM

01:42 PM EDT, 04/25/2024 (MT Newswires) -- Health care stocks were retreating Thursday afternoon, with the NYSE Health Care Index decreasing 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.7%.

The iShares Biotechnology ETF (IBB) fell 1.8%.

In corporate news, Bristol-Myers Squibb ( BMY ) shares plunged almost 9% following its Q1 results.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Economic Data Loom as US Equity Futures Turn Mixed Pre-Bell
Economic Data Loom as US Equity Futures Turn Mixed Pre-Bell
May 25, 2025
08:11 AM EDT, 04/29/2025 (MT Newswires) -- US equity futures were mixed pre-bell Tuesday as traders eyed a string of economic data. Dow Jones Industrial Average futures gained 0.4%, S&P 500 futures slipped 0.1%, and Nasdaq futures were down 0.2%. Investors are also looking ahead to earnings from Microsoft ( MSFT ) , Meta Platforms ( META ) , Apple...
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Economic Data, Mix of Earnings
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Economic Data, Mix of Earnings
May 25, 2025
08:18 AM EDT, 04/29/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was slightly up by 0.03% and the actively traded Invesco QQQ Trust (QQQ) was 0.1% lower in Tuesday's premarket activity as investors await key economic data to be released later in the day, and access a mix of pharmaceutical and...
Regeneron Pharma's first-quarter results miss on lower Eylea demand
Regeneron Pharma's first-quarter results miss on lower Eylea demand
May 25, 2025
(Reuters) -Regeneron missed Wall Street estimates for first-quarter results on Tuesday, hurt by waning demand for its blockbuster eye disease drug Eylea, sending the company's shares tumbling 7% in premarket trading. The drugmaker has been grappling with stiff competition for Eylea from cheaper versions and rivals, including Roche's Vabysmo. Regeneron said Eylea sales were also hit by lower wholesale inventory...
US STOCKS-Wall Street set for mixed open as markets assess earnings, await data
US STOCKS-Wall Street set for mixed open as markets assess earnings, await data
May 25, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Futures: Dow up 0.30%, S&P 500 down 0.13%, Nasdaq off 0.23% * Honeywell gains after rise in Q1 profit * General Motors ( GM ) pulls forecast on tariff uncertainty * Consumer confidence, JOLTS data due on the day...
Copyright 2023-2026 - www.financetom.com All Rights Reserved